← All trials
NCT04606628
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 15, 2020
- Primary completion
- Oct 1, 2021
- Completion date
- Oct 1, 2022
- First posted
- Oct 28, 2020
- Last posted
- Aug 17, 2021
- Enrollment
- 50
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of OsloLead sponsor
- Norwegian University of Life SciencesCollaborator
- University of OsloReponsible party - principal investigator
- Nofima Mat ASCollaborator
- University of OsloCollaborator
- University of OsloOverall official - principal investigator
- NortunaCollaborator
- NoriliaCollaborator
- Orkla HealthCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.